◼ Archived
Business
US approves cheap generic version of breakthrough HIV prevention jab
A promising new HIV-prevention drug is facing significant accessibility challenges in regions where it is most needed, including parts of Africa.
Hiv Prevention
6 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
The FDA has approved the first generic version of the HIV-prevention shot lenacapavir, aiming to expand healthcare access for lower-income countries.
◼ Archived
Health
HIV prevention drug hailed as breakthrough, but who gets access?
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
#Aids2026: We analysed SA’s first LEN roll-out data. Here’s what we found
Analysis of South Africa's first Lenacapavir roll-out data emerges alongside global coverage of the twice-yearly HIV prevention shot.
◼ Archived
Business
🔮 fades
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is establishing global access and licensing frameworks for the world's first monthly oral HIV prevention pill ahead of its official approval.
◼ Archived
Health
🔮 fades
Funding cuts and repressive laws raise risk of new HIV epidemic, says UNAids
Global HIV progress unravels as funding cuts and laws threaten a resurgence of the epidemic, warn UN officials and activists.